Genetic Investigation of Major Ocular Diseases

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000038001

Enrollment

Unknown

Registered

2020-09-08

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All major ocular diseases

Interventions

Case group + control group:Nil

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Ocular disease group: 1. Age-related macular degeneration; 2. Diabetic retinopathy; 3. Glaucoma; 4. Congenital cataract; 5. Ametropia; 6. Strabismus; 7. Uveitis; 8. Orbital diseases; 9. Corneal diseases; 10.Retinal fundus diseases; 11.Other eye diseases; 12.With a clear family history of eye disease, including the affected and unaffected family memebers; Control group: 1.Senile cataract patients without any other eye disease.

Exclusion criteria

Exclusion criteria: 1. With serious systemic diseases, such as coronary heart disease, heart failure, cerebrovascular accident, malignant tumor, etc.; 2. Long-term application of corticosteroid; 3. With active hepatitis B, hepatitis C, syphilis or AIDS, etc.

Design outcomes

Primary

Measure	Time frame
Genetic variation;	—

Countries

China

Contacts

Public ContactMichael Ng TK

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

wzj@jsiec.org+86 754 8839 3560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026